

Please try another search
Daxor Corporation is a medical instrumentation and biotechnology company. The Company is focused on blood volume measurement. The Company has developed and marketed the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the food and drug administration (FDA) to provide objective quantification of blood volume status and composition compared to patient-specific norms. Over 60,000+ tests have been performed at hospital centers across the United States, enhancing hospital performance metrics in a broad range of surgical and medical conditions, including reducing mortality and readmissions in heart failure and critical care. It has ongoing multicenter trials in the areas of COVID-19 and heart failure treatment with support from the National Institutes of Health (NIH) and is under contract developing analyzers.
Name | Age | Since | Title |
---|---|---|---|
James A. Lombard | 88 | 1989 | Independent Director |
Michael Richard Feldschuh | 53 | 2013 | Chairman, President & CEO |
James H. Brassel | - | - | Member of Medical Advisory Board |
Phillip Frost | 86 | - | Chairman of Medical Advisory Board |
Jonathan Adam Feldschuh | 57 | 2017 | Chief Scientific Officer & Director |
Henry D. Cremisi | 64 | 2020 | Independent Director |
Edward S. Feuer | 66 | 2016 | Independent Director |
Fred Gilbert | - | - | Member of Medical Advisory Board |
Joy Goudie | 65 | 2020 | Independent Director |
Caleb DesRosiers | 49 | 2022 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review